Related references
Note: Only part of the references are listed.Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation
Gui Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis
Mark M. Fuster et al.
JOURNAL OF CELL BIOLOGY (2007)
Heparanase enhances syndecan-1 shedding - A novel mechanism for stimulation of tumor growth and metastasis
Yang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Angiopoietin-2 stimulates breast cancer metastasis through the β-501 integrin-mediated pathway
Yorihisha Imanishi et al.
CANCER RESEARCH (2007)
Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin β1-dependent adhesion to the extracellular matrix
Ok-Hee Lee et al.
MOLECULAR CANCER RESEARCH (2006)
Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis
Lars Jakobsson et al.
DEVELOPMENTAL CELL (2006)
Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells
K Ding et al.
JOURNAL OF CELL BIOLOGY (2005)
Angiopoietins in tumours: the angiogenic switch
CR Tait et al.
JOURNAL OF PATHOLOGY (2004)
Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines
M Fukasawa et al.
CLINICAL CANCER RESEARCH (2004)
Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis
RD Sanderson et al.
MATRIX BIOLOGY (2004)
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells
DH Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The medical management of pancreatic cancer: A review
S McKenna et al.
ONCOLOGIST (2003)
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
IB Lobov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Do morphogen gradients arise by diffusion?
AD Lander et al.
DEVELOPMENTAL CELL (2002)
Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases
CC Solorzano et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Proteoglycans: Pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland
M Delehedde et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo
JY Luo et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Developmental roles of the glypicans
B De Cat et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2001)
Mechanisms underlying preferential assembly of heparan sulfate on glypican-1
RL Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glypicans in growth control and cancer
J Filmus
GLYCOBIOLOGY (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
I Kim et al.
ONCOGENE (2000)
Coexpression of FAS and FAS-ligand in chronic pancreatitis: Correlation with apoptosis
M Kornmann et al.
PANCREAS (2000)
Molecular biology of breast cancer metastasis - Molecular expression of vascular markers by aggressive breast cancer cells
MJC Hendrix et al.
BREAST CANCER RESEARCH (2000)
Share Paper
